Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Hirata

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Modern Rheumatology Case Reports|August 11, 2022
Appearance of anti-MDA5 antibody-positive dermatomyositis after COVID-19 vaccinationTomohiro Sugimoto, Ai Yorishima, Naoya Oka, et al.
Modern Rheumatology|May 30, 2018
Predictive factors for structural remission using abatacept: Results from the ABROAD studyKosaku Murakami, Masahiro Sekiguchi, Shintaro Hirata, et al.
Arthritis Research & Therapy|November 30, 2013
Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational studyShintaro Hirata, Kazuyoshi Saito, Satoshi Kubo, et al.
Rheumatology (Oxford, England)|September 4, 2014
Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosusJun Ishizaki, Kazuyoshi Saito, Masao Nawata, et al.
Viruses|July 29, 2023
Tumor Necrosis Factor and Interleukin-1β Upregulate NRP2 Expression and Promote SARS-CoV-2 ProliferationMichinori Ishitoku, Sho Mokuda, Kei Araki, et al.
Internal Medicine (Tokyo, Japan)|November 17, 2022
Cryoglobulinemic Vasculitis Associated with Monoclonal Gammopathy of Undetermined Significance Developed after Sustained Virologic Response of Hepatitis CMichinori Ishitoku, Yusuke Yoshida, Toshiki Matsubara, et al.
Rheumatology (Oxford, England)|April 4, 2017
Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritisShingo Nakayamada, Satoshi Kubo, Maiko Yoshikawa, et al.
Annals of the Rheumatic Diseases|November 30, 2013
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR studyYoshiya Tanaka, Shintaro Hirata, Satoshi Kubo, et al.
Internal Medicine (Tokyo, Japan)|November 17, 2022
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus ErythematosusYusuke Yoshida, Naoya Oka, Ai Yorishima, et al.
Rheumatology (Oxford, England)|February 9, 2013
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt studyShintaro Hirata, Linda Dirven, Yijing Shen, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Modern Rheumatology Case Reports|August 11, 2022
Appearance of anti-MDA5 antibody-positive dermatomyositis after COVID-19 vaccinationTomohiro Sugimoto, Ai Yorishima, Naoya Oka, et al.
Modern Rheumatology|May 30, 2018
Predictive factors for structural remission using abatacept: Results from the ABROAD studyKosaku Murakami, Masahiro Sekiguchi, Shintaro Hirata, et al.
Arthritis Research & Therapy|November 30, 2013
Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational studyShintaro Hirata, Kazuyoshi Saito, Satoshi Kubo, et al.
Rheumatology (Oxford, England)|September 4, 2014
Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosusJun Ishizaki, Kazuyoshi Saito, Masao Nawata, et al.
Viruses|July 29, 2023
Tumor Necrosis Factor and Interleukin-1β Upregulate NRP2 Expression and Promote SARS-CoV-2 ProliferationMichinori Ishitoku, Sho Mokuda, Kei Araki, et al.
Internal Medicine (Tokyo, Japan)|November 17, 2022
Cryoglobulinemic Vasculitis Associated with Monoclonal Gammopathy of Undetermined Significance Developed after Sustained Virologic Response of Hepatitis CMichinori Ishitoku, Yusuke Yoshida, Toshiki Matsubara, et al.
Rheumatology (Oxford, England)|April 4, 2017
Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritisShingo Nakayamada, Satoshi Kubo, Maiko Yoshikawa, et al.
Annals of the Rheumatic Diseases|November 30, 2013
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR studyYoshiya Tanaka, Shintaro Hirata, Satoshi Kubo, et al.
Internal Medicine (Tokyo, Japan)|November 17, 2022
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus ErythematosusYusuke Yoshida, Naoya Oka, Ai Yorishima, et al.
Rheumatology (Oxford, England)|February 9, 2013
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt studyShintaro Hirata, Linda Dirven, Yijing Shen, et al.
Pageof 16